Scentech Medical

Company Overview

Snapshot

Founded in January 2018, Scentech Medical operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing noninvasive real-time screening solutions. In February 2022, Scentech Medical appointed a former manager of the Biological Institute to its leadership, aiming to strengthen its position for a potential merger.

Business overview

Scentech Medical develops noninvasive, real-time screening solutions for infectious diseases, providing instant results through simple breath tests. The company's core technology detects unique metabolic processes associated with pathogens, creating a singular metabolic fingerprint for each. This enables Scentech Medical's Rapid Scent Test to identify various pathogens, even in early, asymptomatic stages of infection. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Devices, serving healthcare providers with its diagnostic devices and software platforms.

Strategic signal

In May 2022, a report from Calcalist highlighted that Scentech Medical was not yet mature for investment and needed a strategic shift. This indicates a critical juncture for the company, suggesting a need for significant operational or strategic adjustments to attract further investment and advance its market readiness.

Company Intelligence Q&A

What is Scentech Medical's primary focus?

Scentech Medical primarily focuses on developing noninvasive, real-time breath diagnostic technology for infectious diseases, providing instant screening results.

What is the core technology behind Scentech Medical's products?

The company's technology detects unique metabolic fingerprints associated with pathogens, allowing for the identification of various infectious agents even in early stages.

What was a key development for Scentech Medical in February 2022?

In February 2022, Scentech Medical brought in a former manager of the Biological Institute to its leadership team, a move aimed at facilitating a potential merger.

What was the outcome of a report regarding Scentech Medical in May 2022?

A May 2022 report from Calcalist indicated that Scentech Medical was not yet ready for investment and required a strategic phase change.

When did Scentech Medical begin early trials for its COVID-19 breathalyzer detector?

In July 2020, Scentech Medical began early tests for its breathalyzer detector for COVID-19, aiming for a 10-second result.